AARTI DRUGS LTD.

{
    "company_profile": "Aarti Drugs Limited is an India-based company, which is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates in the pharmaceuticals segment. Its geographical segments include Out of India and India. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals include benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.",
    "sector": "Pharmaceuticals",
    "sector_market_cap_inr": {
        "value": 3681.83,
        "unit": "crore",
        "formatted": "3,681.83 Cr"
    },
    "sector_market_cap_usd": {
        "value": 409.09,
        "unit": "million",
        "formatted": "$409.09M"
    }
}